214 related articles for article (PubMed ID: 12213538)
1. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
Järbe TU; Andrzejewski ME; DiPatrizio NV
Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
[TBL] [Abstract][Full Text] [Related]
2. The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats.
Järbe TU; DiPatrizio NV; Li C; Makriyannis A
Pharmacol Biochem Behav; 2003 Jul; 75(4):809-21. PubMed ID: 12957223
[TBL] [Abstract][Full Text] [Related]
3. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
4. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.
Järbe TU; DiPatrizio NV; Li C; Makriyannis A
Behav Pharmacol; 2007 Nov; 18(7):673-80. PubMed ID: 17912052
[TBL] [Abstract][Full Text] [Related]
5. (-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats.
Järbe TU; DiPatrizio NV; Lu D; Makriyannis A
Behav Pharmacol; 2004 Nov; 15(7):517-21. PubMed ID: 15472574
[TBL] [Abstract][Full Text] [Related]
6. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
Järbe TU; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
9. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
Darmani NA
Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
[TBL] [Abstract][Full Text] [Related]
10. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
Mansbach RS; Rovetti CC; Winston EN; Lowe JA
Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
[TBL] [Abstract][Full Text] [Related]
11. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
12. Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats.
Järbe TU; Ross T; DiPatrizio NV; Pandarinathan L; Makriyannis A
Pharmacol Biochem Behav; 2006 Sep; 85(1):243-52. PubMed ID: 16996123
[TBL] [Abstract][Full Text] [Related]
13. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
14. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Darmani NA
Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist.
Järbe TU; Harris MY; Li C; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2004 Dec; 177(1-2):35-45. PubMed ID: 15167981
[TBL] [Abstract][Full Text] [Related]
17. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
[TBL] [Abstract][Full Text] [Related]
18. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine.
Williams CM; Kirkham TC
Pharmacol Biochem Behav; 2002; 71(1-2):333-40. PubMed ID: 11812541
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
20. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.
Costa B; Vailati S; Colleoni M
Behav Pharmacol; 1999 May; 10(3):327-31. PubMed ID: 10780247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
